G8, VES-13 and CARG Scores in Predicting Chemotherapy Toxicity in Geriatric Cancer Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-02-01

Study Completion Date

2021-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

All participants' medical information will be collected for use as a baseline, including tumor-specific variables, nutritional status, functional status, psychological status, cognitive function, social support, and comorbidities. The suitability of G8, VES-13 and CARG chemotherapy risk assessment tools for elderly cancer patients was investigated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Predicting Chemo Toxicity Using Geriatric Forms

NCT07163169

Oncology Geriatric Oncology Physiology

ACTIVE_NOT_RECRUITING

Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer

NCT02517034

Solid Neoplasm

ACTIVE_NOT_RECRUITING NA

Predisposing Factors Associated With Chemotherapy Toxicity in Elderly Cancer Patients

NCT02317757

Cancer

UNKNOWN

Understanding Needs of Older Patients Prior to Starting Cancer Treatment

NCT07225920

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

ENROLLING_BY_INVITATION NA

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

NCT02054741

Adult Solid Neoplasm Toxicity Lymphoma

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All participants' medical information will be collected for use as a baseline, including tumor-specific variables, nutritional status, functional status, psychological status, cognitive function, social support, and comorbidities. G8, VES-13 and CARG toxicity scores of all participating patients will be determined by two independent investigators before starting chemotherapy. The suitability of these practical chemotherapy risk assessment tools for cancer patients for elderly cancer patients was investigated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Predicting Chemotherapy Related Toxicity in Elderly Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Older Patients Receiving Chemotherapy

No Intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged ≥65 years
* Localized or metastatic solid carcinoma diagnosed by histology (any type, any stage)
* Starting a new-line (first-line, second-line or third-line) chemotherapy